These alterations have translational relevance to neurodevelopmental disorders for which NRXN1 deletions are a genetic risk factor, including ASD and ScZ, and to individuals with 2p16.3 (NRXN1) deletions. The gene discussed is NRXN1; the disease is neurodevelopmental disorder.